Stock Events

Stock Events

Lonza Group 

€592.00
211
-€3.60-0.6%Friday 12:37

Statistics

Day High
596.4
Day Low
590.4
52W High
-
52W Low
-
Volume
47
Avg. Volume
-
Mkt Cap
41.35B
P/E Ratio
18.54
Dividend Yield
0.36%
Dividend
2.13

Upcoming

Dividends

0.36%Dividend Yield
May 2026
€2.13
May 2025
€2.13
May 2024
€2.04
May 2023
€1.79
May 2022
€1.43
10Y Growth
N/A
5Y Growth
12.15%
3Y Growth
5.91%
1Y Growth
N/A

Earnings

Jul 22Expected
Q4 2024
Q2 2025
Q4 2025
Q2 2026
7.56
8.37
9.19
10
Expected EPS
9.42986621392683
Actual EPS
8.846017156799999

Financials

9.66%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
6.92BRevenue
668.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LO3.XETRA. It's not an investment recommendation.
Nestle SA
55
NESN.SW
Novartis
45
NOVN.SW
Microsoft
42
MSFT
Swiss Re
36
SREN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap150.48B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap13.85B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap42.5B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
West Pharmaceutical Services
WST
Mkt Cap25.69B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.

About

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries, as well as develops cell and gene therapies. The company also provides drinking water sanitizers, nutraceuticals, antidandruff agents, and other personal care ingredients; and agricultural products and advanced coatings and composites, as well as microbial control solutions that combat dangerous viruses, bacteria, and other pathogens. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Show More
CEO
Employees
15375
Country
Germany
ISIN
CH0013841017
WKN
000928619

Listings

MI
IT
1LONN.MI
XETRA
DE
LO3.XETRA
MX
MX
LONNN.MX
MU
DE
LO3.MU

0 Comments

Share your thoughts

FAQs

What is Lonza Group stock price today?▼
The current price of LO3.XETRA is €592.00 EUR — it has decreased by -0.6% in the past 24 hours. Watch Lonza Group stock price performance more closely on the chart.
What is Lonza Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Lonza Group stocks are traded under the ticker LO3.XETRA.
Is Lonza Group stock price growing?▼
LO3.XETRA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Lonza Group has showed a +5% increase.
What is Lonza Group market cap?▼
Today Lonza Group has the market capitalization of 41.35B
When is the next Lonza Group earnings date?▼
Lonza Group is going to release the next earnings report on January 27, 2027.
What were Lonza Group earnings last quarter?▼
LO3.XETRA earnings for the last quarter are 8.85 EUR per share, whereas the estimation was 9.43 EUR resulting in a -6.19% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Lonza Group revenue for the last year?▼
Lonza Group revenue for the last year amounts to 6.92B EUR.
What is Lonza Group net income for the last year?▼
LO3.XETRA net income for the last year is 668.49M EUR.
Does Lonza Group pay dividends?▼
Yes, LO3.XETRA dividends are paid annual. The last dividend per share was 2.13 . As of today, Dividend Yield (FWD)% is 0.36%.
How many employees does Lonza Group have?▼
As of October 18, 2026, the company has 15,375 employees.
In which sector is Lonza Group located?▼
Lonza Group operates in the Materials sector.
When did Lonza Group complete a stock split?▼
Lonza Group has not had any recent stock splits.